(IN BRIEF) A collaborative study by the University of Copenhagen and Stanford University has revealed that pharmaceuticals possess unique isotopic signatures—based on stable isotopes of carbon, hydrogen and oxygen—that correspond to their manufacturing conditions. By profiling these δ²H, δ¹³C and … Read the full press release
Posted in Business, Denmark, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged cellulose, corn starch, counterfeit detection, Else Holmfred, excipients, ibuprofen, isotope-ratio mass spectrometry, isotopes, partnership, pharmaceutical counterfeiting, stable isotope analysis, Stanford University, Stefan Stürup, University of Copenhagen, δ²H, δ¹³C, δ¹⁸O
(IN BRIEF) Sanofi has finalized its takeover of Vigil Neuroscience for roughly $470 million, acquiring all outstanding shares at $8 each and issuing a $2-per-share CVR tied to VG-3927’s first commercial sale. This deal, following Sanofi’s June 2024 strategic investment, … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged acquisition, Alzheimer’s disease, contingent value right, CVR, neurodegenerative research, Neurology, partnership, Phase 2 clinical study, preclinical pipeline, Sanofi, strategic investment, TREM2 agonist, VG-3927, VGL101, Vigil Neuroscience
(IN BRIEF) Almirall and Absci have expanded their AI-based drug discovery collaboration by selecting a second dermatological target, following the initial success of AI-designed antibody leads against a difficult-to-drug protein. Their partnership, active since November 2023, leverages Absci’s Integrated Drug … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Spain, Technology
Tagged Absci, AI drug discovery, Almirall, antibody leads, biotech collaboration, chronic skin disease, clinical development, de-novo design, Dermatology, generative AI, Integrated Drug Creation, Karl Ziegelbauer, milestone payments, partnership, Sean McClain, second target, wet-lab validation
(IN BRIEF) Researchers at the University of Glasgow’s School of Chemistry have developed a novel, catalyst-free ultrasound method to destroy bisphenol A (BPA) in water. By applying two ultrasound frequencies simultaneously, their prototype generates cavitation bubbles that reach extreme temperature … Read the full press release
Posted in Chemicals, Education, Environment, Healthcare, Science, Technology, United Kingdom
Tagged bisphénol A, BPA removal, cavitation bubbles, chemical oxygen demand, Dr Lukman Yusuf, Dr Zelika Ertekin, dual-frequency, EPSRC, methylene blue, PFAS, Professor Mark Symes, Royal Society, School of Chemistry, Shaun Fletcher, sonochemistry, sustainable technology, Symes Group, Ultrasonics Sonochemistry, ultrasound, University of Glasgow, water treatment
(IN BRIEF) Fresenius Kabi has licensed rights from Polpharma Biologics to commercialize the vedolizumab biosimilar candidate PB016 globally—except in the Middle East and North Africa—once approved. Vedolizumab treats Crohn’s disease and ulcerative colitis, and PB016 references Takeda’s Entyvio®. The transaction … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Poland, Science, Technology
Tagged #FutureFresenius, (Bio)Pharma portfolio, chronic inflammatory diseases, Crohn's disease, denosumab biosimilar, Dr. Sang-Jin Pak, EC Approval, Entyvio, FDA approval, Fresenius Kabi, global commercialization, Konstantin Matentzoglu, licensing agreement, partnership, PB016, Polpharma Biologics S.A., Ulcerative colitis, Ustekinumab Biosimilar, vedolizumab biosimilar
(IN BRIEF) Salzgitter AG has introduced a bike-leasing program in collaboration with Lease a Bike (VW Financial Services), enabling employees to lease e-bikes, mountain bikes, or road bikes via salary conversion. Since its July launch, about 2,000 staff registered and … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, Metals and Minerals, News, Technology
Tagged Anthony Bandmann, bike leasing, Birgit Dietze, Christian Wölbern, e-bikes, Employee Wellbeing, environmental impact, flexible commuting, green workplace, Lease A Bike, mountain bikes, partnership, road bikes, salary conversion, Salzgitter AG, sustainability, sustainable mobility, Volkswagen Financial Services
(IN BRIEF) EssilorLuxottica has acquired Automation & Robotics (A&R), a Belgian leader in automated lens-quality metrology, whose proprietary machinery and software have supported optical manufacturers’ digital transitions since 1983. The deal strengthens EssilorLuxottica’s industrial-solutions portfolio—extending its capabilities from standard ophthalmic … Read the full press release
Posted in Apparel, Fashion & Beauty, Belgium, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Technology
Tagged acquisition, AR, automated systems, Automation & Robotics, digital transformation, EssilorLuxottica, Francesco Milleri, Industrial Solutions, mass production, metrology, optical lens quality control, partnership, Paul du Saillant, prescription laboratories, proprietary technology, R&D, software development, vertical integration, vision care, wearable optics
(IN BRIEF) APM Terminals Nigeria has launched two local sustainability initiatives: in Onne, the WACT-APM Terminals sanitary pad programme trains students to produce reusable menstrual products, improving hygiene, reducing stigma, combating school absenteeism and cutting plastic waste; in Apapa, a … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Netherlands, News, Technology, Transportation & Logistics
Tagged Apapa, APM Terminals Nigeria, Centre for Creative Development Strategies, circular economy, CO₂ emissions reduction, CSR, Dufy Global Enterprise, GIVO, Lagos, menstrual hygiene, Net-Zero by 2040, Onne, partnership, plastic waste reduction, reusable sanitary pads, Rivers State, school absenteeism, solar-powered recycling hub, sustainability, WACT-APM Terminals
(IN BRIEF) From 16–19 July, Liverpool hosted the IAOO’s 10th World Congress at ACC Liverpool, attracting over a thousand delegates from 55 countries. Organised by University of Liverpool experts and supported by Liverpool City Council, the congress focused on oral … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Technology, United Kingdom
Tagged ACC Liverpool, Dr Caroline McCarthy, early diagnosis, head and neck cancers, IAOO, Institute of Systems Molecular and Integrative Biology, International Academy of Oral Oncology, Liverpool, Liverpool City Council, Liverpool Diagnostic Infrared Wand, Liverpool Head & Neck Centre, Machine Learning, oral cancer, prevention, Professor Andrew Schache, Professor Chris Butterworth, Professor Christian Ottensmeier, Professor Jo Patterson, Professor Matt Ashton, Professor Richard Shaw, Survivorship, treatment, University of Liverpool
(IN BRIEF) Basilea Pharmaceutica has initiated FORWARD‑IM, a global Phase 3 trial evaluating fosmanogepix in adults with invasive mold infections. Building on positive Phase 1 and Phase 2 results—and following the FAST‑IC Phase 3 candidemia trial—this open‑label study will randomize about 160 patients to … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged Amplyx Pharmaceuticals, Aspergillus spp., BARDA, Basilea Pharmaceutica Ltd, broad‑spectrum antifungal, Candida auris, candidemia, Cresemba®, FAST‑IC, FDA Fast Track, FORWARD‑IM, fosmanogepix, Fusarium spp., HHS ASPR, invasive candidiasis, invasive mold infections, Lomentospora prolificans, Mucorales, orphan drug, Pfizer, phase 3 study, PSI CRO AG, QIDP, Zevtera®
(IN BRIEF) Crédit Agricole Santé & Territoires has finalized its takeover of Petits‑fils, the leading national franchise for at‑home senior care in France, following regulatory clearance from the French Competition Authority. The deal—valued at around €243 million—integrates more than 290 Petits‑fils … Read the full press release
Posted in Banks, Business, Economy, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Technology
Tagged aging‑in‑place, at‑home senior care, Clariane, Crédit Agricole Santé & Territoires, demographic transition, franchise network, French Competition Authority, mutualist heritage, partnership, Petits‑fils, Pierre Guillocheau
(IN BRIEF) Synaptiq is streamlining radiotherapy preparation with its AI‑driven contouring software, which automates the delineation of tumours and organs at risk. Founded by Dragoș Dușe and Roxana Săbău, the Romanian startup emerged from research at Germany’s Cancer Research Centre and now … Read the full press release
Posted in Artificial Intelligence (AI), Banks, Business, Economy, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Romania, Technology, United Kingdom
Tagged AI contouring, cancer care innovation, cancer research, clinical expansion, CT, Dragoș Dușe, EBRD, healthtech, Heidelberg, MRI, organs at risk, partnership, patent, prompt‑based AI, radiotherapy, Romania, Roxana Săbău, Star Venture programme, Synaptiq, TaiwanBusiness-EBRD Technical Cooperation Fund, tumour delineation
(IN BRIEF) An international panel led by Professor Craig Williams (University of Exeter) has issued updated guidelines on assessing physical activity in cystic fibrosis patients, published in the European Respiratory Review. The 2025 position statement recommends prioritising wearable technology—trackers, smartwatches … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged activity prescription, Cystic Fibrosis, Dr Don Urquhart, Dr Thomas Radtke, European Cystic Fibrosis Society, European Respiratory Review, Exercise Working Group, fitness trackers, guideline update 2025, hospital admissions, long‑term outcomes, patient longevity, physical activity assessment, Professor Craig Williams, sedentary behaviour, sensor‑embedded clothing, sleep monitoring, smartwatches, standardised measurement, University of Exeter, wearable devices
(IN BRIEF) The EU‑funded AI4HF project is co‑designing, developing and evaluating a trustworthy AI tool to personalise heart failure care. Engaging over 200 stakeholders—including patients, clinicians and administrators—from Europe, South America and Africa, the project has held multiple workshops to … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged AI in healthcare, AI4HF, Amsterdam, Amsterdam UMC, Autumn 2025, Barcelona, bias mitigation, Brno, Clinical/Patient Working Groups, Dar es Salaam, ESC Digital Cardiology and AI Committee, European Heart Network, European Society of Cardiology, health literacy, heart failure, high‑dimensional data, Horizon Europe Framework, lifestyle recommendations, Lima, multi‑stakeholder workshops, partnership, personalised medicine, personalised risk assessment, Professor Folkert W. Asselbergs, shared decision-making, SHINE 2Europe, symptom interpretation, trustworthy AI
(IN BRIEF) The FDA has accepted AstraZeneca’s sBLA for Imfinzi as a perioperative immunotherapy regimen in resectable early‑stage and locally advanced gastric and GEJ cancers, granting Priority Review with a decision expected in Q4 2025. The application leverages MATTERHORN Phase III data … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged 2025 decision, adjuvant, AstraZeneca, breakthrough therapy designation, clinical paradigm shift, durvalumab, early-stage, EFS hazard ratio, event-free survival, FDA priority review, FLOT chemotherapy, gastric cancer, gastroesophageal junction cancer, high unmet need, Imfinzi, Levi Garraway, locally advanced, MATTERHORN Phase III, neoadjuvant, overall survival, Perioperative Immunotherapy, resectable, sBLA, Susan Galbraith
(IN BRIEF) Roche’s ongoing Phase Ib/IIa Brainshuttle™ AD study of trontinemab shows that 91 percent of participants reach amyloid PET negativity, with ARIA‑E rates under 5 percent. The company has outlined Phase III TRONTIER 1 and 2 trials in early symptomatic Alzheimer’s for 2025, plus a planned … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Alzheimer’s Association International Conference, amyloid plaques, amyloid‑beta monoclonal antibody, ARIA‑E, blood‑based biomarker, blood‑brain barrier, Brainshuttle, centiloids, clinical dementia rating sum of boxes, cognitive decline, diagnostics, early diagnosis, Elecsys pTau217, Levi Garraway, Matt Sause, PET negativity, Phase Ib/IIa, Phase III TRONTIER 1, Phase III TRONTIER 2, preclinical Alzheimer’s, pTau181, pTau217/Ab42 ratio, Roche, sustainability of clinical trials, TRAVELLER, trontinemab
(IN BRIEF) Mindray has received EU MDR Notified Body Certificates for three core surgical products—Articulating Endoscopic Linear Cutter and Reloads, Polymer Ligation Clip, and Reusable Electrode Surgical Instruments—awarded by TÜV Rheinland Greater China on July 11, 2025. This certification marks … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Security & Safety, Technology
Tagged 2025 certifications, Articulating Endoscopic Linear Cutter, CE marking, Chinese medical devices, clinical safety, EU market access, EU MDR, Global Expansion, Hangzhou Mindray Medical Technology, healthcare manufacturing, INNOVATION, ISO 13485, IVDR, MDSAP, medical device certification, Mindray, minimally invasive surgery, Nanjing, partnership, Polymer Ligation Clip, R&D, regulatory compliance, Reusable Electrode Surgical Instruments, Shao Lingyun, Tony Chen, TÜV Rheinland, Wang Wenlong, Wendy Geng, Zhang Haifeng, Zuo Pengfei
(IN BRIEF) GSK has entered into a multi-programme development and licensing agreement with Hengrui Pharma to advance up to 12 innovative therapies, including HRS-9821, a potentially best-in-class PDE3/4 inhibitor currently in clinical trials for COPD. The deal includes $500 million … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AI-era medicine, biopharma partnership, Chronic obstructive pulmonary disease, clinical development, cloud healthcare, COPD treatment, drug innovation, drug pipeline, dry powder inhaler, Frank Jiang, global health, GSK, Hart-Scott-Rodino Act, Hengrui Pharma, HRS-9821, immunology, inflammation, licensing agreement, milestone payments, novel therapeutics, oncology, partnership, PDE3/4 inhibitor, pharmaceutical collaboration, phase I trials, respiratory medicine, Tony Wood
(IN BRIEF) Pfizer and BioNTech have received a positive recommendation from the EMA’s CHMP for their LP.8.1-adapted monovalent COVID-19 vaccine, COMIRNATY® LP.8.1, for individuals aged six months and older. This updated vaccine offers improved immune protection against prevalent SARS-CoV-2 subvariants, … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, News, Pharma & Biotech, Science, Technology
Tagged BioNTech, booster, CHMP, COMIRNATY LP.8.1, COVID-19 vaccine, EMA, EU vaccine rollout, European Commission, immune response, LP.8.1 variant, mRNA technology, mRNA Vaccine, NB.1.8.1 variant, Pandemic Preparedness, pediatric COVID vaccine, Pfizer, public health, SARS-CoV-2, vaccine adaptation, XFG variant
(IN BRIEF) AstraZeneca’s Trixeo Aerosphere has received a positive opinion from the EMA’s CHMP for use with a new propellant that offers a 99.9% reduction in Global Warming Potential compared to traditional formulations. Trixeo becomes the first pressurised metered-dose inhaler … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Ambition Zero Carbon, AMPLIFY Phase III trial, AstraZeneca, Barbara Eichhorst, Breztri, BTK inhibitor, budesonide, Calquence, chemoimmunotherapy, CHMP, chronic lymphocytic leukaemia, climate action in pharma, clinical trial, CLL, COPD, Dave Fredrickson, EMA, environmental sustainability, European approval, European Commission approval, European Union, fixed-duration regimen, formoterol fumarate, Frederik Trinkmann, glycopyrronium, hematologic diseases, hematology, Honeywell, inhalers, leukemia, low GWP, next-generation propellant, obinutuzumab, oncology, pMDI, progression-free survival, Respiratory Care, Ruud Dobber, Susanna Palkonen, Sustainable Healthcare, treatment option, Trixeo Aerosphere, venetoclax
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?